🇺🇸 FDA
Patent

US 11613551

Aminoglycoside derivatives and uses thereof in treating genetic disorders

granted A61PA61P13/12A61P17/00

Quick answer

US patent 11613551 (Aminoglycoside derivatives and uses thereof in treating genetic disorders) held by ELOXX PHARMACEUTICALS LTD. expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ELOXX PHARMACEUTICALS LTD.
Grant date
Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P13/12, A61P17/00, A61P21/00, A61P21/04